CAS No. |
62-90-8 |
中文名称 |
(8R,9S,10R,13S,14S,17S)-13-甲基-3-氧代-2,3,6,7,8,9,10,11,12,13,14,15,16,17-十四氢-1H-环戊并[a]菲-17-基3-苯基丙酸酯 |
英文名称 |
(8R,9S,10R,13S,14S,17S)-13-methyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl 3-phenylpropanoate |
别名 |
Z31791378 | Equibolin | Nadrolone phenylpropionate | Norandrostenolone phenylpropionate | 19Ntpp | BRN 3170861 | D1813 | AKOS015888240 | CS-0206618 | Tox21_113342 | NANDROLONE PHENPROPIONATE [ORANGE BOOK] | Nandrolone phenpropionate [USP] | NANDROLONE PHE |
标准英文名 |
(8R,9S,10R,13S,14S,17S)-13-methyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl 3-phenylpropanoate |
分子式 |
C27H34O3 |
分子量 |
406.57
|
精确分子量 |
406.25
|
SMILES |
C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@H]43)[C@@H]1CC[C@@H]2OC(=O)CCC1=CC=CC=C1 |
标准SMILES |
C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@H]43)[C@@H]1CC[C@@H]2OC(=O)CCC1C=CC=CC=1 |
用途 |
Treatment of growth retardation, malnutrition, and cachectic conditions; management of severe osteoporosis, premature infants, dwarfism, and severe nutritional deficiency; adjunctive therapy for negative nitrogen balance caused by high-dose corticosteroid use in dermatology; treatment of exfoliative dermatitis, pemphigus, dermatomyositis, scleroderma, and senile pruritus; supportive care in severe burns, perioperative periods of malignant tumors, non-union fractures, chronic diarrhea, anorexia, and other severe wasting diseases; palliative treatment of inoperable breast cancer; management of dysfunctional uterine bleeding and uterine fibroids. |
InChIKey |
UBWXUGDQUBIEIZ-QNTYDACNSA-N |